150 related articles for article (PubMed ID: 2847650)
1. Mode of action of a new type of UDP-glucose analog against herpesvirus replication.
Alarcón B; González ME; Carrasco L; Méndez-Castrillón PP; García-López MT; de las Heras FG
Antimicrob Agents Chemother; 1988 Aug; 32(8):1257-61. PubMed ID: 2847650
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of the antiherpesvirus biflavone ginkgetin.
Hayashi K; Hayashi T; Morita N
Antimicrob Agents Chemother; 1992 Sep; 36(9):1890-3. PubMed ID: 1329635
[TBL] [Abstract][Full Text] [Related]
3. Cell culture replication of herpes simplex virus and, or human cytomegalovirus is inhibited by 3,7-dialkoxylated, 1-hydroxyacridone derivatives.
Lowden CT; Bastow KF
Antiviral Res; 2003 Aug; 59(3):143-54. PubMed ID: 12927304
[TBL] [Abstract][Full Text] [Related]
4. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of herpes simplex virus type 2 replication in vitro by 1-N-pentadecanoyl-3''-N-trifluoroacetyl kanamycin A.
Rahman MM; Yamamoto N; Morishima T; Maeno K; Nishiyama Y
Antiviral Res; 1988; 9(1-2):11-22. PubMed ID: 2839107
[TBL] [Abstract][Full Text] [Related]
6. Characterization of inhibitory action of concanamycins against herpes simplex virus.
Hayashi K; Kawauchi M; Nakai C; Sankawa U; Seto H; Hayashi T
Antivir Chem Chemother; 2001 Jan; 12(1):51-9. PubMed ID: 11437322
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins.
Schang LM; Bantly A; Knockaert M; Shaheen F; Meijer L; Malim MH; Gray NS; Schaffer PA
J Virol; 2002 Aug; 76(15):7874-82. PubMed ID: 12097601
[TBL] [Abstract][Full Text] [Related]
8. Involvement of membrane traffic in the replication of poliovirus genomes: effects of brefeldin A.
Irurzun A; Perez L; Carrasco L
Virology; 1992 Nov; 191(1):166-75. PubMed ID: 1329315
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of uridine 5'-diphosphate glucose analogues against some enveloped viruses in cell culture.
Gil-Fernández G; Pérez S; Vilas P; Pérez C; de las Heras FG; García Gancedo A
Antiviral Res; 1987 Dec; 8(5-6):299-310. PubMed ID: 2837144
[TBL] [Abstract][Full Text] [Related]
10. Polysaccharides as antiviral agents: antiviral activity of carrageenan.
González ME; Alarcón B; Carrasco L
Antimicrob Agents Chemother; 1987 Sep; 31(9):1388-93. PubMed ID: 2823697
[TBL] [Abstract][Full Text] [Related]
11. Mechanism and mode of action of 5-iodo-2-pyrimidinone 2'-deoxyribonucleoside, a potent anti-herpes simplex virus compound, in herpes simplex virus-infected cells.
Lewandowski GA; Cheng YC
Mol Pharmacol; 1991 Jan; 39(1):27-33. PubMed ID: 1846219
[TBL] [Abstract][Full Text] [Related]
12. In vitro antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against herpes simplex virus and poliovirus.
Amoros M; Fauconnier B; Girre RL
Antiviral Res; 1987 Aug; 8(1):13-25. PubMed ID: 2825589
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of 5-(2-chloroethyl)-2'-deoxyuridine, a selective inhibitor of herpes simplex virus replication.
De Clercq E; Bernaerts R; Merta A; Rosenwirth B
Mol Pharmacol; 1990 May; 37(5):658-64. PubMed ID: 2160059
[TBL] [Abstract][Full Text] [Related]
14. Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils.
Machida H; Sakata S; Kuninaka A; Yoshino H
Antimicrob Agents Chemother; 1981 Jul; 20(1):47-52. PubMed ID: 6269482
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of herpes simplex virus type 1 replication by halothane.
Bedows E; Holland TC; Knight PR
Antimicrob Agents Chemother; 1986 May; 29(5):941-4. PubMed ID: 3015010
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways.
Sanchez MD; Ochoa AC; Foster TP
Antiviral Res; 2016 Aug; 132():13-25. PubMed ID: 27192555
[TBL] [Abstract][Full Text] [Related]
17. The antiviral activity against herpes simplex virus of the triterpenoid compounds carbenoxolone sodium and cicloxolone sodium.
Dargan DJ; Subak-Sharpe JH
J Antimicrob Chemother; 1986 Oct; 18 Suppl B():185-200. PubMed ID: 3025156
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo antiviral activity of 2'-fluorinated arabinosides of 5-(2-haloalkyl)uracil.
Rosenwirth B; Streicher W; De Clercq E; Wanek E; Schwarz W; Griengl H
Antiviral Res; 1987 Jun; 7(5):271-87. PubMed ID: 2821896
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of herpes simplex virus production in vitro by cyclosporin A.
Vahlne A; Larsson PA; Horal P; Ahlmén J; Svennerholm B; Gronowitz JS; Olofsson S
Arch Virol; 1992; 122(1-2):61-75. PubMed ID: 1309645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
